Galanin NAX 810-2 - Galanin Receptor-2 Based Therapy
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
University of Utah; NeuroAdjuvants, Inc., Epilepsy Foundation (EF), Milken Family Foundation
Mechanism of Action
Other
Mechanism Description
Activates galanin receptor subtype 2
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2006
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link